Xeris Biopharma Holdings, Inc. (XERS)
10.75
+0.11
(+1.03%)
USD |
NASDAQ |
Oct 29, 16:00
11.50
+0.75
(+6.98%)
After-Hours: 05:11
Xeris Biopharma Holdings Price : 10.75 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | 10.80 | 10.94 | 10.70 | 10.75 | 1.746M |
| Oct 28, 2026 | 10.45 | 10.75 | 10.39 | 10.64 | 1.452M |
| Oct 27, 2026 | 10.16 | 10.48 | 10.10 | 10.45 | 1.522M |
| Oct 26, 2026 | 10.22 | 10.40 | 10.12 | 10.21 | 1.905M |
| Oct 23, 2026 | 10.85 | 10.85 | 10.06 | 10.20 | 2.372M |
| Oct 22, 2026 | 10.81 | 10.98 | 10.67 | 10.86 | 1.411M |
| Oct 21, 2026 | 11.14 | 11.28 | 10.77 | 10.78 | 1.682M |
| Oct 20, 2026 | 11.00 | 11.35 | 10.96 | 11.13 | 2.901M |
| Oct 19, 2026 | 10.34 | 11.42 | 10.34 | 10.95 | 4.344M |
| Oct 16, 2026 | 10.04 | 10.33 | 9.840 | 10.31 | 2.289M |
| Oct 15, 2026 | 9.77 | 10.18 | 9.76 | 10.07 | 1.942M |
| Oct 14, 2026 | 10.08 | 10.39 | 9.73 | 9.77 | 2.367M |
| Oct 13, 2026 | 10.41 | 10.50 | 10.15 | 10.20 | 2.220M |
| Oct 12, 2026 | 10.46 | 10.55 | 10.32 | 10.46 | 1.329M |
| Oct 09, 2026 | 10.15 | 10.60 | 10.07 | 10.48 | 2.995M |
| Oct 08, 2026 | 10.10 | 10.35 | 10.00 | 10.19 | 1.979M |
| Oct 07, 2026 | 10.00 | 10.27 | 9.91 | 10.11 | 2.221M |
| Oct 06, 2026 | 10.23 | 10.32 | 9.90 | 10.07 | 2.404M |
| Oct 05, 2026 | 9.15 | 10.24 | 9.12 | 10.13 | 4.665M |
| Oct 02, 2026 | 9.34 | 9.34 | 9.035 | 9.08 | 1.804M |
| Oct 01, 2026 | 9.52 | 9.69 | 9.175 | 9.25 | 3.591M |
| Sep 30, 2026 | 9.97 | 10.07 | 9.545 | 9.56 | 3.753M |
| Sep 29, 2026 | 9.77 | 11.33 | 9.50 | 9.98 | 19.31M |
| Sep 28, 2026 | 9.05 | 10.00 | 9.00 | 9.83 | 4.463M |
| Sep 25, 2026 | 8.99 | 9.15 | 8.850 | 9.10 | 1.547M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Zevra Therapeutics, Inc. | 10.36 |
| ANI Pharmaceuticals, Inc. | 73.16 |
| Corcept Therapeutics, Inc. | 85.95 |
| Veru, Inc. | 2.23 |
| Johnson & Johnson | 275.20 |
Price Related Metrics
| PS Ratio | 5.674 |
| Price to Free Cash Flow | 34.19 |
| Earnings Yield | -0.95% |
| Market Cap | 1.866B |
| Operating PE Ratio | 52.01 |
| Normalized PE Ratio | 482.06 |